Who invested in Elixiron Immunotherapeutics?
Elixiron Immunotherapeutics's investors include Taiwania Capital.

Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2025, from 1 source
Elixiron Immunotherapeutics's investors include Taiwania Capital.
Elixiron Immunotherapeutics has raised 1 round since 2025, none with a disclosed amount.
Elixiron Immunotherapeutics's most recent round was a Venture in Jun 2025.
Elixiron Immunotherapeutics's first round on record, in Jun 2025, was backed by Taiwania Capital.
Elixiron Immunotherapeutics's latest named round is a Venture, in Jun 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.